AZYMAB

Welcome to the Brand page for “AZYMAB”, which is offered here for Therapeutic, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, cancer, autoimmune and inflammatory diseases;licensing of proprietary intellectual property;scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment and prophylaxis of human diseases, disorders and conditions, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “AZYMAB” is believed to be currently owned by “Zymeworks Inc.”